Released Nov 13, 2012, during market hours
10-Q filed Nov 13, 2012, 44 days after period end · 0001144204-12-061299
Q3 2012 · 10-Q
Revenue—
Net Income-$5.36M-$5.36M N/M vs Q3 2011N/M vs Q2 2012
EPS Diluted-$0.41-$0.41 N/M vs Q3 2011N/M vs Q2 2012
Operating Income-$5,370,303N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Net Income | -$5.36M | -$5.80M | -$1.78M |
| EPS Diluted | -$0.41 | -$0.50 | -$3.97 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR